Skip to main content
SpringerLink
Log in

A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2)

  • ASO Research Letter
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gronchi A, Miceli R, Shurell E, Eilber FC, Eilber FR, Anaya DA, et al. Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. J Clin Oncol. 2013;31(13):1649–55.

    Article  PubMed  Google Scholar 

  2. Gronchi A, Strauss DC, Miceli R, Bonvalot S, Swallow CJ, Hohenberger P, et al. Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the Multi-Institutional Collaborative RPS Working Group. Ann Surg. 2016;263(5):1002–9.

    Article  PubMed  Google Scholar 

  3. Park JO, Qin LX, Prete FP, Antonescu C, Brennan MF, Singer S. Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule. Ann Surg. 2009;250(6):977–82.

    Article  PubMed  Google Scholar 

  4. Thomas DM, O’Sullivan B, Gronchi A. Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management. Expert Rev Anticancer Ther. 2009;9(8):1145–57.

    Article  PubMed  Google Scholar 

  5. Bonvalot S, Gronchi A, Le Péchoux C, Swallow CJ, Strauss D, Meeus P, et al. Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2020;21(10):1366–77.

    Article  PubMed  Google Scholar 

  6. Callegaro D, Raut CP, Ajayi T, Strauss D, Bonvalot S, Ng D, et al. Preoperative radiotherapy in patients with primary retroperitoneal sarcoma: EORTC-62092 trial (STRASS) versus off-trial (STREXIT) results. Ann Surg. 2022. https://doi.org/10.1097/SLA.0000000000005492.

    Article  PubMed  Google Scholar 

  7. Trans-Atlantic RPS Working Group. Management of recurrent retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the Trans-Atlantic RPS Working Group. Ann Surg Oncol. 2016;23(11):3531–40.

    Article  PubMed Central  Google Scholar 

  8. D’Ambrosio L, Touati N, Blay JY, Grignani G, Flippot R, Czarnecka AM, et al. Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: a propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Cancer. 2020;126(11):2637–47.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

    Jacob Lambdin MD, Carrie Ryan MD, MS, Stephanie Gregory MD & Jonathan M. Hernandez MD

  2. Division of Surgical Oncology, Winship Cancer Institute, Emory University Hospital Midtown, Atlanta, Georgia, USA

    Kenneth Cardona MD

  3. The Netherlands Cancer Institute — Antoni Van Leeuwenhoekziekenhuis, Amsterdam, The Netherlands

    Winan J. van Houdt MD, PhD

  4. Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy

    Alessandro Gronchi MD

Authors
  1. Jacob Lambdin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carrie Ryan MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephanie Gregory MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenneth Cardona MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jonathan M. Hernandez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Winan J. van Houdt MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alessandro Gronchi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Jonathan M. Hernandez MD or Alessandro Gronchi MD.

Ethics declarations

Disclosure

The authors declare they have no conflicts of interest and nothing to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PNG 256 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lambdin, J., Ryan, C., Gregory, S. et al. A Randomized Phase III Study of Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Patients with High-Risk Retroperitoneal Sarcoma (STRASS2). Ann Surg Oncol 30, 4573–4575 (2023). https://doi.org/10.1245/s10434-023-13500-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13500-9

Search

Navigation